Trademark: 97862513
Word
ADD
Status
Pending
Status Code
653
Status Date
Sunday, March 10, 2024
Serial Number
97862513
Mark Type
4000
Filing Date
Wednesday, March 29, 2023

Trademark Owner History

Classifications
9 Downloadable computer software platform used for collecting and analyzing data in the field of healthcare and optimization of healthcare, clinical and hospital processes; downloadable computer software and downloadable computer firmware used for automating control of medical equipment; downloadable computer software for information management, data collection and data analysis of medical equipment, all of the above for pharmaceutical, life sciences, medical devices and healthcare providers; downloadable computer software for clinical trials and drug development; downloadable computer software for database analysis and management; computer hardware and downloadable software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; downloadable computer software platform for pharmacovigilance that enables automation of case processing and supports diverse data source formats; downloadable computer software to automate drug regulatory processes and compliance with drug registration; downloadable computer software for controlling and managing patient medical information
35 Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, drug development and applications for drug approval; Computerized file management includes data related to drug development, regulatory compliance, and pharmacovigilance
42 Scientific research, study and research consultation in the fields of medicine, drug delivery, clinical trials, drug development; laboratory research in the field of new drug development; Design and development of computer software for pharmacovigilance, medicine, drug delivery, clinical trials, drug development, automate drug regulatory processes and compliance with drug registration; online non-downloadable computer software to provide aforementioned services using artificial intelligence and machine learning techniques; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Research and development of vaccines and medicines; Consultancy relating to quality control; Advisory services relating to all the aforesaid services; online non-downloadable computer software services for pharmacovigilance; scientific and technological services, namely, research and design in the field of pharmaceutical, drug development, clinical trials, life sciences, and medical devices; Software as a Service (SaaS) featuring software for data collection, data management and data analytics, Platform as a Service (PaaS) featuring software for data collection, data management and data analytics in the fields of medicine, drug delivery, clinical trials, drug development, automate drug regulatory processes and compliance with drug registration; online non-downloadable computer software for data collection, data management and data analytics in the fields of medicine, drug delivery, clinical trials, drug development, automate drug regulatory processes and compliance with drug registration using artificial intelligence and machine learning techniques

Trademark Events
Mar 10, 2024
Notification Of Letter Of Suspension E-Mailed
Mar 10, 2024
Letter Of Suspension E-Mailed
Mar 10, 2024
Suspension Letter Written
Jan 26, 2024
Teas/Email Correspondence Entered
Jan 25, 2024
Correspondence Received In Law Office
Jan 25, 2024
Teas Response To Office Action Received
Jan 16, 2024
Notification Of Non-Final Action E-Mailed
Jan 16, 2024
Non-Final Action E-Mailed
Jan 16, 2024
Non-Final Action Written
Dec 21, 2023
Assigned To Examiner
Oct 16, 2023
Teas Voluntary Amendment Received
Apr 20, 2023
New Application Office Supplied Data Entered
Apr 1, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24